Application Nr Approved Date Route Status External Links
ANDA040066 None Ophthalmic None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage: For The Treatment Of Conjunctivitis And Other Superficial Ocular Infections Due To Susceptible Microorganisms, And As An Adjunctive In Systemic Sulfonamide Therapy Of Trachoma: Escherichia Coli, Staphylococcus Aureus, Streptococcus Pneumoniae, Streptococcus (Viridans Group), Haemophilus Influenzae, Klebsiella Species, And Enterobacter Species. Topically Applied Sulfonamides Do Not Provide Adequate Coverage Against Neisseria Species, Serratia Marcescens And Pseudomonas Aeruginosa . A Significant Percentage Of Staphylococcal Isolates Are Completely Resistant To Sulfa Drugs.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Sulfacetamide Sodium SULFACETAMIDE SODIUM ZINC5179119

Comments